
Filings buzz in pharmaceuticals: 3Q21 sees a 20% decrease in digitalization mentions
Still, pharma companies mentioned digitalization in their filings 421% more often in 3Q21 than in the same quarter in 2016
ByStill, pharma companies mentioned digitalization in their filings 421% more often in 3Q21 than in the same quarter in 2016
ByIn November 2021, 3.6% of newly posted job advertisements were future of work-related job opportunities
ByOf the 50 biggest employers in pharma, Lonza Group referred to industrial automation the most between July 2020 and June…
ByPfizer has acquired US-based Amplyx Pharmaceuticals to advance its expertise in infectious disease and expand its anti-infectives pipeline.
Three companies have merged to form the UK’s first nationwide life sciences ecosystem, boosting R&D and drug discovery capacity in…
ByVertex Pharmaceuticals (VRTX) and Obsidian Therapeutics have entered a strategic research partnership and licensing agreement to discover and develop novel…
Janux Therapeutics has raised $125m through a series B funding round to advance its pipeline of next-generation T cell engager…
AstraZeneca’s proposed $39bn acquisition of rare disease therapy company Alexion Pharmaceuticals has passed a US Federal Trade Commission review.
ByThank you for subscribing to Pharmaceutical Technology